← Eichor
Study identifier: NCT06780202 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Condition: Foot Injuries and Disorders · Ankle Injuries and Disorders · Achilles Tendon Injury  ·  Sponsor: Emory University

PhasePhase 2
Planned participants180
Who can joinAll sexes, 18 Years to 95 Years
Healthy volunteersNo

About this study

This clinical trial aims to determine the effects of a 6-day low-dose methylprednisolone course on pain, nausea, and total opioid consumption in patients undergoing foot and ankle surgeries. The secondary objective of the study is to determine and monitor the effects of the course on complications following surgery and patient-reported outcomes

This description comes directly from the study's public registry record.

Talk to the study team

Jason Bariteau, MD  ·  404-778-3350  ·  jason.bariteau@emory.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Emory Musculoskeletal Institute, Emory Orthopaedics & Spine CenterAtlanta, Georgia, United StatesRecruiting
Emory Sports Medicine Complex and Emory Orthopaedics and Spine CenterJohns Creek, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06780202